Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current therapy for malignant mesothelioma.

W Roy Smythe1

  • 1Multidisciplinary Mesothelioma Thoracic Oncology Program, Department of Thoracic and Cardiovascular Surgery, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Box 445, Houston, USA. rsmythe@mail.mdanderson.org

Current Oncology Reports
|June 5, 2002
PubMed
Summary

This review covers current treatments for malignant mesothelioma, including chemotherapy, surgery, and radiotherapy. It also explores promising new molecular and biologic therapies based on preclinical and early clinical research.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Re-evaluating breast malignant pleural effusion: toward evidence-based, precision-aligned care with organoids.

Frontiers in bioengineering and biotechnology·2026
Same author

The patient journey and guideline-concordant care in colorectal cancer-is current practice enough?

Frontiers in medicine·2026
Same author

RECOMBINANT BCL-XL ATTENUATES VASCULAR HYPERPERMEABILITY IN A RAT MODEL OF HEMORRHAGIC SHOCK.

Cell death discovery·2016
Same author

Can laparoscopic cholecystectomy be performed with a positive margin at medicaid reimbursement rates?

Journal of the American College of Surgeons·2014
Same author

Thymic neuroendocrine carcinoma producing ectopic adrenocorticotropic hormone and Cushing's syndrome.

The Annals of thoracic surgery·2013
Same author

Implementation of a surgical safety checklist: impact on surgical team perspectives.

Ochsner journal·2013

Area of Science:

  • Oncology
  • Thoracic Surgery
  • Medical Oncology

Background:

  • Malignant mesothelioma is an aggressive cancer with limited treatment options.
  • Systemic and local therapies have shown varying efficacy in managing this disease.

Purpose of the Study:

  • To review existing treatment modalities for malignant mesothelioma.
  • To highlight the potential of novel molecular and biologic therapies.

Main Methods:

  • Literature review of systemic treatments (chemotherapy).
  • Literature review of local treatments (surgery, radiotherapy).
  • Summary of preclinical and early clinical research on new therapies.

Main Results:

  • Past treatments like chemotherapy, surgery, and radiotherapy have been evaluated.

Related Experiment Videos

  • Emerging molecular and biologic therapies show potential in early-stage research.

    • Conclusions:

    • Current treatment strategies for malignant mesothelioma are discussed.
    • Future therapeutic avenues involving targeted and immune-based therapies are promising.